Emily See is a Critical Care Nephrologist and Research Fellow in the Department of Intensive Care at Austin Health, Melbourne. She completed her renal training at University Hospital Geelong, Princess Alexandra Hospital, and Monash Health, and is currently undertaking a PhD examining the long-term sequelae of acute kidney injury, with the aim of developing an evidence-based model of care for high-risk survivors. Her other clinical interests include renal replacement therapy for acute and chronic kidney diseases, ultrafiltration rate and volume management in haemodialysis, and the diagnosis and management of complement-mediated thrombotic microangiopathies. She is an active member of several academic groups, including the steering committee and renal biopsy guideline group of KHA CARI and the haemodialysis working group of the ANZDATA Registry. She has published over 20 peer-reviewed articles and 3 book chapters, acts as a reviewer for several high-impact journals in the fields of nephrology, critical care, and internal medicine, and has received 5 national and international awards for clinical and basic science research. She has a strong interest in medical statistics and clinical epidemiology and is completing an MSc in Medical Statistics through the University of Oxford, investigating novel methodology for clinical risk prediction in chronic disease.